From High-Potent APIs to Bioconjugation: Enabling the Next Generation of ADC Therapies
- Outlining TAPI’s capabilities in HPAPIs and bioconjugation
- Exploring innovation in containment, compliance, and sustainability
- Assessing strategic ADC collaborations and future outlook